| Authors: |
Corral J; Clínica Universidad de Navarra, Madrid, 28027, Spain., Mok TS; State Key Laboratory of South China, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, PR China., Nakagawa K; Kindai University Hospital, Osaka, 589-8511, Japan., Rosell R; Catalan Institute of Oncology, Barcelona, Spain., Lee KH; Chungbuk National University Hospital, Cheongju, Korea., Migliorino MR; Pulmonary Oncology Unit, San Camillo-Forlanini Hospital, Rome, 00152, Italy., Pluzanski A; The Maria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology, Warsaw, 02-781, Poland., Linke R; SFJ Pharmaceuticals®, Pleasanton, CA 94588, USA., Devgan G; Pfizer Oncology, New York, NY 10017, USA., Tan W; Pfizer Clinical Pharmacology, San Diego, CA 92121, USA., Quinn S; Pfizer Oncology, Cambridge, MA 02139, USA., Wang T; Pfizer Oncology, Groton, CT 06340, USA., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, PR China. |
